NCT00993226 - An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy | Biotech Hunter

Enrollment

115

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

December 31, 2009

Study Completion Date

July 31, 2010

Conditions

Postoperative Pain

Interventions

DRUG

SABER-Bupivacaine Treatment 1a

5.0 ml

DRUG

Placebo SABER-Bupivacaine Treatment 1b

5.0 ml

DRUG

Bupivacaine HCl Treatment 1c

40 ml

DRUG

SABER-Bupivacaine Treatment 2a

7.5 ml

DRUG

Placebo SABER-Bupivacaine Treatment 2b

7.5 ml

DRUG

Bupivacaine HCl Treatment 2c

40 ml

Trial Locations (14)

Nycomed, Paris

Nycomed, Bayreuth

Nycomed, Dresden

Nycomed, Békéscsaba

Nycomed, Budapest

Nycomed, Debrecen

Nycomed, Győr

Nycomed, Nyíregyháza

Nycomed, Székesfehérvár

Nycomed, Szolnok

Nycomed, Tatabánya

Nycomed, Riga

Nycomed, Stockholm

Nycomed, London